GP5, the principal envelope glycoprotein of porcine reproductive and respiratory syndrome virus (PRRSV), contains a hypervariable region within the ectodomain which is responsible for generating diversity in field isolates. The purpose of this study was to gain insight into the possible origin of this diversity by following GP5 sequence changes in pigs exposed to PRRSV strain VR-2332 in utero. A region of the PRRS virus genome containing portions of ORF4 and ORF5 was amplified directly from tissues of infected pigs from birth to 132 days of age. We observed the emergence of a new PRRSV population, identified by a single nucleotide change in the ectodomain. The Asp to Asn change at amino acid 34 was also found as a minor component in pigs that expressed the wild-type sequence. The results from this study suggest that the variability in the ectodomain of ORF5 is the result of positive or negative selection, of which the mechanism remains to be determined.
Porcine reproductive and respiratory syndrome (PRRS) is caused by an enveloped positive-stranded RNA virus, PRRSV, belonging to the family Arteriviridae. This group also includes lactate dehydrogenase-elevating virus (LDV) of mice, equine arteritis virus (EAV), and simian hemorrhagic fever virus (1) . The ORF5 protein, known as GP5 in PRRSV, VP3 in LDV, and GL in EAV, is the predominant viral envelope glycoprotein. The domains within the ORF5 proteins of PRRSV and LDV include a signal peptide (removed after translation), an ectodomain, a three-transmembrane region, and an endodomain (1) (2) (3) . The ectodomains of LDV and PRRSV are relatively short, approximately 30 amino acids in length, and possess up to three glycosylation sites. The heavily glycosylated ectodomain of LDV is the portion of VP3 which interacts with receptor on macrophages. Amino acid variations within the LDV ectodomain affect several aspects of pathogenesis, including the elimination of virus by neutralizing antibody, cell tropism, and the maintenance of persistent infection (1, 3) . The role of the ectodomain of GP5 in PRRSV pathogenesis is less well understood. Among PRRSV field isolates, the peptide signal sequence and distal portion of the ectodomain forms a hypervariable region (4, 5) . This variation affects the amino acid sequence and number of N-glycosylation sites (6) (7) (8) . The origin of this diversity is not known, but the ectodomain may define a region under selection by antibody or other host defenses 5, 9-11). However, other structural proteins, such as GP4, may represent additional targets for neutralization antibody (12) . Another possibility is that GP5 variation reflects neutral selection of random RNA mutations.
The purpose of this study was to gain insight into the possible origin of the diversity in ORF5 by following nucleotide changes in a group of pigs first exposed to PRRSV in utero. Using this experimental approach, we were able to follow mutations that appeared throughout the period of infection, beginning with the acute infection of neonates through adulthood. Another advantage of this approach was the simulation of herd conditions frequently found in the field.
Three PRRSV-negative sows were infected intranasally with 10 5 TCID 50 of VR-2332, a North American PRRSV isolate (13) . The virus used for inoculation was prepared from a single plaque and amplified by passaging the virus two additional times on MARC-145 cells (14) . The sows were allowed to farrow at 114 days and piglets weaned 19 days later. After weaning, the litters were placed together as single group. All pigs displayed clinical disease signs typical of PRRSV. The mortality within 3 weeks was 50%. Pigs eventually recovered and by 50 days no longer exhibited signs of acute disease and remained asymptomatic.
A region of the VR-2332 containing the last 312 nt of ORF4, a 10-nt untranslated region, and the first 215 nt of ORF5 was amplified from total RNA extracted from tissue ( Fig. 1) . The incorporation of the ORF4 sequence provided the opportunity to compare ORF5 to a region of the genome that is relatively conserved (8) . The first tissues were collected from umbilical cords, which is representative of virus present in pigs prior to the appearance of neutralizing antibody. (Neutralizing activity was first detected in the herd at 8 days after farrowing). The sequences obtained at 1 to 17 days after farrowing were from pigs that died from either PRRS or a combination of PRRS and Streptococcus suis, a common infection of PRRSV-infected piglets. The remaining sequences were from asymptomatic pigs randomly removed from the herd between 63 and 132 days. Four pigs were retained for more than 1 year then sacrificed. We attempted to obtain RT-PCR products from these long-term pigs but were not successful.
GP4 sequences in umbilical cords and subsequent tissues were almost completely identical to parental VR-2332 (data not shown). The only exception was a silent mutation, C to T at nucleotide position 406 of ORF4, in the umbilical cords of pigs 194 and 186. Both pigs were from the same litter. The GP5 sequence in umbilical cords was identical to that of the parental VR-2332, except for an arginine to glycine substitution at amino acid 32 in pig 186 (Fig. 2) . Forty-six percent (7 of 15 pigs) of the postumbilical cord GP5 sequences, obtained from the direct sequencing of PCR products, contained a single mutation, the substitution of asparagine (Asn) for an aspartic acid (Asp) at amino acid position 34. In each case the mutation was an A to G change at nucleotide 100 of ORF5. After 15 passages of the VR-2332 derived RespPRRS vaccine on MARC-145 cells, only one amino acid change was observed, an arginine to glutamine change at amino acid 13 within the signal peptide. Viruses from pigs 20, 26, and 61 were isolated on MARC-145 cells. Sequence analysis of infected cells confirmed the presence of the Asn-34 mutation in each pig. The Asn-34 mutation appeared as early as 8 days after farrowing, but was absent from pigs as late as 75 days (pig 68) and 104 days (pigs 16 and 72) and was found in at least one pig in all three litters. To determine if the Asn-34 mutation was tissuespecific, PCR products from more than one tissue were sequenced, e.g., thymus, spleen, and thoracic lymph node from pig 69; thoracic lymph node and spleen from pig 71; salivary gland, kidney, medial inguinal lymph node, and testes from pig 26; and tonsil, bladder, liver, and spleen from pig 20. In all cases, the sequences in each pig were the same, irrespective of the tissue (data not shown). This analysis was not performed at 63 days and beyond, since lymph nodes and tonsil were the only tissues that yielded PCR products.
To determine if the Asp-34 pigs possessed the Asn-34 virus as a minor population, PCR products were cloned and individual clones sequenced. A summary of these results is presented in Table 1 . The Asn-34 sequence was not identified in 25 cloned PCR products obtained from umbilical cords of pig 188 and pig 186 and of pig 188 after virus isolation on MARC-145 cells. We continued to search for the Asn-34 subpopulation by looking at tissues from several pigs identified as possessing the Asp-34 sequence. In pigs 192 (9 days), 187 (14 days), and 72 (100 days), the cloned products contained a mixture of Asn-34 and Asp-34 sequences. These results suggest that the Asn-34 virus was absent, or at a very low frequency, during neonatal infection, but emerged sometime after birth. The cloned PCR products revealed other variants, including defective genomes (or subgenomes), identified by the presence of premature stop codons.
After removal of the signal peptide between amino acids 31 and 32 of GP5, the Asn mutation would be located near the amino-terminus of the ectodomain, within the hypervariable region (4, 5) . Another feature of this change is the addition of a new, overlapping, Nglycosylation site. Such sites are identified by the sequences NXS or NXT (X cannot be proline). The appearance of Asn at position 34 in GP5 changes NDSS to NNSS.
Neutralizing antibody, directed against GP5 or PRRSV, blocks infection of MARC-145 cells (9-11); however, serum neutralizing activity during infection of pigs is typically low and shows a wide variation in onset and magnitude (15) . In addition, neutralizing antibody against one isolate frequently shows reduced neutralizing activity against other isolates (16) . In an attempt to identify neutralizing antibody as the source of the selective pressure driving the emergence of the Asn-34 mutation, virusneutralizing activity in sera was measured against an Asn-34 virus (isolated from a lymph node of pig 61 at 17 days after farrowing) and an Asp-34 virus (isolated from a lymph node of pig 187 at 14 days) (Fig. 3) . All serum FIG. 1 . RT-PCR amplification of a segment containing the 3Ј end of ORF4, the 5Ј end of ORF5, and the intervening untranslated region. RT-PCR was performed using a modification of the technique described by Christopher-Hennings et al. (18) . cDNA was prepared from total RNA using MLV reverse transcriptase and 4MSB as the primer. Primer sequences were obtained from the published VR-2332 sequence (GenBank Accession No. U87392). The sense and antisense primers for the outer amplification were 4MSA, 5Ј-CTTCGTCCCTTCTTTTCCTCGTGG, and 4MSB, 5Ј-CCGCTCTAGAGCCAACGATAGAGTCTGC, respectively. The product was reamplified with a nested set of sense and antisense primers, 04A, 5Ј-ACCGTGTATGTTACCATCACAGCC, and 04B, ACGG-GAAAGATGACAAAACTCTCC. Thirty-two cycles of amplification were performed for each primer pair. The conditions for both amplifications included a 95°C denaturing step (25 s), a 58°C annealing step (10 s), and a 74°C (25 s) polymerization step. The final product, which contained the last 312 nucleotides of ORF4, the 10-nucleotide untranslated region (UTR), and the first 215 nucleotides of ORF5, was sequenced on an Applied Biosystems 377A automated sequencer. samples contained neutralizing activity, which ranged between titers of 4.0 and 6.6. The principal difference between sera obtained from Asn-34 and Asp-34 (wildtype) pigs was an average decrease in neutralizing activity of Asn-34 sera against the Asn-34 virus; however, this decrease was not statistically significant. From this experiment it is difficult to assess the role of neutralizing antibody in the selection of the Asn-34 mutation, since antibody in each pig was probably produced against a mixture of both Asp-34 and Asn-34 viruses ( Table 1) .
The possible relevance of the Asn-34 mutation was also investigated by sequencing viruses from naïve pigs which were accidentally contaminated. The original experiment included a litter of six control, uninfected pigs, a Umbilical cords and tissues from pigs in Fig. 2 were chosen for analysis. Individual PCR products were cloned into the pCR2.1-TOPO cloning vector (Invitrogen). Clones identified as containing an insert were sequenced.
b Sequence information obtained from clones after isolation of virus on MARC-145 cells.
born at the same time as the infected pigs. Within 1 week after farrowing the control pigs became infected due to a break in biosecurity. The contact pigs were sacrificed, and RT-PCR was performed on tissues. GP5 sequences from all six pigs contained the Asn-34 mutation.
In this study we observed the emergence of a distinct PRRSV population, identified by a single amino acid change in the ectodomain of GP5. The origin of the Asn-34 mutation is not known. One possibility is the presence of the Asn-34 mutation as a minor component in the original inoculum used to infect the pregnant sows. Data suggesting this possibility are found by comparing the umbilical cord and tissue sequences in pig 186 (Fig. 2) . The GP5 sequence in the umbilical cord, which contained a glycine at position 32 and aspartic acid at position 34, was displaced by a sequence containing serine at position 32 and asparagine at position 34.
During replication, RNA viruses can mutate at frequencies approaching one mutation for every 10,000 nucleotides. Negative selection, positive selection, and random sampling of these mutations are the principal forces driving the emergence of new RNA viruses (17) . How the Asn-34 mutation improves the fitness of VR-2332 is not known. In a similar experiment using a different North American PRRSV isolate. SDSU-23983, we observed the appearance of a new virus population identified by a mutation at amino acid 33 of GP5. However, this change did not affect the glycosylation site. Studies using LDV demonstrate how a small number of mutations in the ectodomain of the ORF5 protein can alter cell tropism and interaction of virus with neutralizing antibody. LDVc, which replicates in motor neurons and macrophages, is sensitive to neutralizing antibody and establishes a relatively low level of virus replication in the periphery. During infection of mice with LDVc, subpopulations that possess two additional glycosylation sites in the ectodomain of the ORF5 protein appear. This new virus population no longer infects motor neurons, is resistant to neutralizing antibody, and establishes a relatively higher level of virus replication during persistence (3). This study suggests that the variation in GP5 among field isolates arises from positive or negative selection. The advantages that these changes offer to the PRRS virus during acute and persistent phases of infection remain to be determined. However, it is interesting to note that over time PRRSV replication limits tropism to cells in lymphoid tissues, predominantly tonsil and lymph nodes. This suggests that selection favors viruses capable of persisting in these tissues.
